Navigation Links
Zealand Pharma and Boehringer Ingelheim Enter Into a Licence and Collaboration Agreement to Advance Novel Compounds to Treat Type-2 Diabetes and Obesity
Date:6/15/2011

researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

As a central element of its culture, Boehringer Ingelheim pledges to act socially responsible. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavours.

In 2010, Boehringer Ingelheim posted net sales of about 12.6 billion euro while spending almost 24% of net sales in its largest business segment Prescription Medicines on research and development.

For more information please visit http://www.boehringer-ingelheim.com

For further information, please contact:
Zealand Pharma A/S
David H. Solomon, President and Chief Executive Officer;
Tel: +45-4328-1210 or Mobile: +45-2220-6300

Hanne Leth Hillman, Vice President, Head of Investor Relations and Corporate Communications;
Tel: +45-8877-3689 or Mobile: +45-5060-3689

Boehringer Ingelheim
Julia Meyer-Kleinmann, Director Corporate Communications, Boehringer Ingelheim GmbH;
Tel: +49-6132-77-8271, press@boehringer-ingelheim.com



'/>"/>
SOURCE Zealand Pharma A/S
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NxStage® Advances Global Growth Strategy with System One™ Regulatory Approval and Distribution Agreement in Australia and New Zealand
2. Prostate Cancer Patients Benefit from New Zealand Centers Adoption of Elekta VMAT Radiotherapy Technique
3. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
4. Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market
5. Dr. Assad Al-Ammar Joins Irvine Pharmaceutical Services as the New Minerals Analysis Manager in Response to the Growing Needs for USP Elemental Impurities Testing
6. ViroPharmas Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE)
7. Saint-Gobains New C-Flex® ULTRA Pump Tubing for Biopharmaceutical Applications Outperforms the Competition
8. Inovio Pharmaceuticals to Present at Scientific & Industry Conferences
9. Neurelis Announces Positive Results from Phase 1 Pharmacokinetic Study of NRL-01 (intranasal diazepam)
10. Caraco Announces Stockholder Approval of Merger Agreement with Sun Pharma and Consummation of the Merger
11. Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 30, 2015  A new way for people to ... own health and first aid, is being introduced to the ... has a funding goal of $70,000, which needs to be ... aid bracelet to market. This device was inspired by the ... fact that emergencies occur every day. While medical alert bracelets ...
(Date:6/30/2015)... 30, 2015 Zynerba Pharmaceuticals, Inc. today announced that ... the U.S. Securities and Exchange Commission (SEC) relating to the ... of shares to be offered and the price range for ... LLC and Piper Jaffray & Co. will act ... Inc. and Oppenheimer & Co. Inc. will act as co-managers ...
(Date:6/30/2015)... June 30, 2015   Millar, Inc. , a ... announced the 2016 retirement of Craig Thummel , ... 12 years of service to the Company. The Company ... senior members of the Executive Management team as his ... Daugherty , currently Director of Sales and Marketing, as ...
Breaking Medicine Technology:Amyko Propels Medical Alert Bracelets Into the Modern Era 2Zynerba Files Registration Statement for Proposed Initial Public Offering of Common Stock 2Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3
... SAN DIEGO, July 27, 2011 Marshall Edwards, ... focused on the clinical development of novel therapeutics ... from a pre-clinical study of NV-128 showing activity ... the prodrug of the Company,s investigational compound and ...
...   The Next Call ... .   Relevant R&D Topics Include but not ... The BIRD Foundation announced its next ... focusing on innovative R&D collaborations between US and Israeli companies. ...
Cached Medicine Technology:Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian Cancer Stem Cells 2Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian Cancer Stem Cells 3Opportunities for Funding US-Israel Cooperation in Innovative Technologies 2
(Date:6/30/2015)... ... June 30, 2015 , ... ... pending in a federal multidistrict litigation now underway in the U.S. District Court, ... monthly Status Conference. According to the Court’s calendar, that conference has now been ...
(Date:6/30/2015)... , ... June 30, 2015 , ... The U.S. Women's National Soccer Team will ... The first match will be on Sunday, August 16th at Heinz Field in Pittsburgh at ... meet again at Finley Stadium in Chattanooga, TN. , The USA WNT previously played at ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... discussed the advantages that fat transfer procedures had over breast implants when reconstructing ... techniques create breasts that “look and feel natural,” have increased sensation, and are ...
(Date:6/30/2015)... ... June 30, 2015 , ... LifeAID Beverage Company has ... leading organizations dedicated to raising worldwide awareness of the burgeoning “adaptive” movement, I ... now the official charity of FitAID. I AM ADAPTIVE is a non-profit whose ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... NJ Top ... On May 13th, she hosted a CPR Course for members of the Bergen County ... can get updated on the latest CPR recommendations for Healthcare Providers. Life Support ...
Breaking Medicine News(10 mins):Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 3Health News:USA vs. Costa Rica Tickets at Heinz Field in Pittsburgh and Finley Stadium in Chattanooga: Ticket Down Slashes Presale Ticket Prices for Costa Rica vs. USA WNT 2Health News:Recent Article Advocating for Breast Reconstruction with Fat Transfers Successfully Outlines the Advantages of Transfer Procedures, Notes Beverly Hills Physicians 2Health News:Recent Article Advocating for Breast Reconstruction with Fat Transfers Successfully Outlines the Advantages of Transfer Procedures, Notes Beverly Hills Physicians 3Health News:LifeAID Beverage Company Partners With The Adaptive Movement 2Health News:LifeAID Beverage Company Partners With The Adaptive Movement 3Health News:NJ Top Dentists Presents, Dr. Susan Goldfarb of Advanced Periodontics & Implant Care! 2Health News:NJ Top Dentists Presents, Dr. Susan Goldfarb of Advanced Periodontics & Implant Care! 3
... Tenn., Dec. 1 It is a cold December day ... and LPGA star Morgan Pressel have gathered here -- but ... of the biggest names in,professional golf to Memphis is something ... cancer. , (Photo: ...
... Quarter --, -- Fully ... ... TSX Venture Exchange: NVC , , RICHMOND, ... device company, today announced financial results for the third quarter and nine months ...
... PICK: Harnessing miRNA natural gene repressors for anticancer therapy ... Sloan-Kettering Cancer Center, New York, have developed a new ... purposes, and used this to mediate effective anticancer therapy ... miRNAs are powerful natural repressors of gene expression. In ...
... ViroPharma Incorporated,(Nasdaq: VPHM ) today announced that the ... Food and Drug Administration,(FDA) for Cinryze(TM) C1 Inhibitor (human) as ... The sBLA is based on ... acute treatment study of Cinryze and interim data from an ...
... ETHICON, Inc., a Johnson & Johnson company, announced ... Wound Care business to One Equity Partners. Financial terms ... , Under the terms of the transaction, ... portfolio, which contains such advanced wound care brands as PROMOGRAN ...
... and resources , , MONDAY, Dec. 1 (HealthDay ... a poor job safeguarding the nation,s food supply, the ... detailing its efforts to protect consumers. , Among the ... to build better relationships with state and local health ...
Cached Medicine News:Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 2Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 3Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 4Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 5Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 6Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 7Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 2Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 3Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 4Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 5Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 6Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 7Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 8Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 9Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 10Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 11Health News:JCI online early table of contents: Dec. 1, 2008 2Health News:JCI online early table of contents: Dec. 1, 2008 3Health News:JCI online early table of contents: Dec. 1, 2008 4Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 2Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 3Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 4Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 5Health News:ETHICON Completes Divestiture of Professional Wound Care Business to One Equity Partners 2Health News:ETHICON Completes Divestiture of Professional Wound Care Business to One Equity Partners 3Health News:FDA Touts Efforts to Enhance Food Safety 2Health News:FDA Touts Efforts to Enhance Food Safety 3Health News:FDA Touts Efforts to Enhance Food Safety 4
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Each handle is designed to fit a specific trephine size....
Medicine Products: